MarketCap
Theravance Biopharma TBPH
$ 17.03
0.03%
Facebook
X
Telegram
Theravance Biopharma DIO Ratio | TBPH
Annual DIO Ratio Theravance Biopharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 1.02 K | 1.54 K | 784 | 1.13 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.54 K | 784 | 1.12 K |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Clovis Oncology
CLVS
|
271 | - | -7.23 % | $ 13 M |  USA |
 |
BioMarin Pharmaceutical
BMRN
|
644 | $ 60.26 | 0.06 % | $ 11.6 B | USA |
 |
Catalyst Biosciences
CBIO
|
214 | $ 13.99 | 0.84 % | $ 1.25 B | USA |
 |
Codexis
CDXS
|
70.7 | $ 1.32 | 1.09 % | $ 115 M | USA |
 |
Cerus Corporation
CERS
|
213 | $ 2.62 | 0.38 % | $ 499 M | USA |
 |
Coherus BioSciences
CHRS
|
97.5 | $ 1.13 | 0.43 % | $ 132 M | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
221 | $ 4.25 | 3.16 % | $ 51.9 M |  Israel |
 |
AbbVie
ABBV
|
91.6 | $ 264.34 | 0.09 % | $ 468 B | USA |
 |
Cocrystal Pharma
COCP
|
60.5 | $ 1.17 | 1.74 % | $ 13.2 M | USA |
 |
Abeona Therapeutics
ABEO
|
654 | $ 5.4 | 2.65 % | $ 286 M | USA |
 |
Collegium Pharmaceutical
COLL
|
181 | $ 22.53 | 0.2 % | $ 713 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
356 | $ 116.1 | 4.93 % | $ 12.1 B | USA |
 |
Фармсинтез
LIFE
|
120 | - | - | - |  Russia |
 |
CorMedix
CRMD
|
308 | $ 7.85 | 1.03 % | $ 565 K | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
343 | $ 84.95 | 0.13 % | $ 7.99 B | USA |